RT30 mg

Retatrutide 30 mg

Reta, also known as Retatrutide, is an investigational peptide studied for its interaction with GLP-1, GIP, and glucagon receptors at the cellular level. Research explores its effects on metabolic signaling, insulin sensitivity pathways, and energy regulation mechanisms in vitro.

$219.00 USD

Shipping calculated at checkout.

Research use only

All products sold on this website are for research and laboratory purposes only. They are not for human or animal use, including injection, ingestion, or any other form of administration. These products are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for legitimate laboratory research and not for human or animal consumption.

Purity Retatrutide 30 mg

Certificate of Analysis

Third-party tested for 99% purity, ID, quantity.

The development of Reta, also known as Retatrutide, builds on decades of research into incretin-based therapies for metabolic disorders. Early studies with GLP-1 receptor agonists established their role in glucose homeostasis and appetite regulation. Subsequent research expanded to dual agonists like tirzepatide (GLP-1/GIP), paving the way for Retatrutide, which uniquely integrates GLP-1, GIP, and glucagon receptor activity. This multi-agonist design reflects a new direction in peptide therapeutics aimed at investigating more comprehensive metabolic modulation in laboratory and clinical settings.

RT30 contains Retratrutide, an advanced multi-agonist research peptide studied for its interaction with multiple metabolic receptors. It is primarily utilized in cutting-edge laboratory research focused on systemic energy regulation and metabolic signaling. Reta, also known as Retatrutide, has been examined in metabolic and systemic models, with studies highlighting its influence on glucose regulation, insulin signaling, lipid metabolism, and integrated hormone pathways. Research also points to its role in energy balance and multi-system signaling in preclinical and laboratory settings.

Key Areas of Research:

• Metabolic: Glucose, insulin, energy regulation

• Endocrine: GLP-1, GIP, glucagon pathways

• Cardiovascular: Lipid, cholesterol, hepatic signaling

• Systemic: Multi-hormone signaling, resilience, balance

Together, these findings suggest broad experimental potential for Retatrutide across metabolic, cardiovascular, and systemic models. By engaging multiple hormone pathways, it provides a versatile research platform for studying energy regulation, lipid metabolism, and integrated signaling across diverse biological systems.

Energy balance and expenditure pathways
Metabolic optimization research models
Appetite and nutrient signaling studies
Endocrine and hormonal integration research

Retatrutide Structure

CAS #: 2381089-83-2

Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈

Molecular Weight: 4845.44 g/mol

PubChem ID: 474492335

Purity: ≥99%, third-party tested.
Batch / Lot: Provided on vial label and confirmed at delivery.
Certificate of Analysis (per batch): Provided at delivery for the shipped lot/batch.

Store in a cool, dry, dark place and minimize exposure to heat, moisture, light, and air. Avoid unnecessary temperature changes and reseal promptly after use. For full best practices and detailed guidance, read our Storage & Handling page.